137 related articles for article (PubMed ID: 22963163)
1. Insensitivity to scope in contingent valuation studies: reason for dismissal of valuations?
Søgaard R; Lindholt J; Gyrd-Hansen D
Appl Health Econ Health Policy; 2012 Nov; 10(6):397-405. PubMed ID: 22963163
[TBL] [Abstract][Full Text] [Related]
2. Insensitivity to scope in contingent valuation studies: new direction for an old problem.
Whitty JA
Appl Health Econ Health Policy; 2012 Nov; 10(6):361-3. PubMed ID: 22974467
[No Abstract] [Full Text] [Related]
3. Scope and scale insensitivities in a contingent valuation study of risk reductions.
Norinder A; Hjalte K; Persson U
Health Policy; 2001 Aug; 57(2):141-53. PubMed ID: 11395179
[TBL] [Abstract][Full Text] [Related]
4. A comparison of two methods for eliciting contingent valuations of colorectal cancer screening.
Whynes DK; Frew E; Wolstenholme JL
J Health Econ; 2003 Jul; 22(4):555-74. PubMed ID: 12842315
[TBL] [Abstract][Full Text] [Related]
5. Valuation of health changes with the contingent valuation method: a test of scope and question order effects.
Kartman B; Stålhammar NO; Johannesson M
Health Econ; 1996; 5(6):531-41. PubMed ID: 9003940
[TBL] [Abstract][Full Text] [Related]
6. Scope insensitivity in contingent valuation of complex environmental amenities.
Veisten K; Fredrik Hoen H; Navrud S; Strand J
J Environ Manage; 2004 Dec; 73(4):317-31. PubMed ID: 15531390
[TBL] [Abstract][Full Text] [Related]
7. Individual responsibility and health-risk behaviour: a contingent valuation study from the ex ante societal perspective.
van der Star SM; van den Berg B
Health Policy; 2011 Aug; 101(3):300-11. PubMed ID: 21168930
[TBL] [Abstract][Full Text] [Related]
8. When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care.
O'Brien B; Gafni A
Med Decis Making; 1996; 16(3):288-99. PubMed ID: 8818128
[TBL] [Abstract][Full Text] [Related]
9. Assessing the value of a new pharmaceutical. A feasibility study of contingent valuation in managed care.
O'Brien BJ; Goeree R; Gafni A; Torrance GW; Pauly MV; Erder H; Rusthoven J; Weeks J; Cahill M; LaMont B
Med Care; 1998 Mar; 36(3):370-84. PubMed ID: 9520961
[TBL] [Abstract][Full Text] [Related]
10. The value of informal care--a further investigation of the feasibility of contingent valuation in informal caregivers.
de Meijer C; Brouwer W; Koopmanschap M; van den Berg B; van Exel J
Health Econ; 2010 Jul; 19(7):755-71. PubMed ID: 19548326
[TBL] [Abstract][Full Text] [Related]
11. Framing the willingness-to-pay question: impact on response patterns and mean willingness to pay.
Gyrd-Hansen D; Jensen ML; Kjaer T
Health Econ; 2014 May; 23(5):550-63. PubMed ID: 23696155
[TBL] [Abstract][Full Text] [Related]
12. Aiding priority setting in health care: is there a role for the contingent valuation method?
Olsen JA
Health Econ; 1997; 6(6):603-12. PubMed ID: 9466142
[TBL] [Abstract][Full Text] [Related]
13. The measurement of contingent valuation for health economics.
Bayoumi AM
Pharmacoeconomics; 2004; 22(11):691-700. PubMed ID: 15250748
[TBL] [Abstract][Full Text] [Related]
14. Willingness to pay for publicly financed health care services in Central and Eastern Europe: evidence from six countries based on a contingent valuation method.
Tambor M; Pavlova M; Rechel B; Golinowska S; Sowada C; Groot W
Soc Sci Med; 2014 Sep; 116():193-201. PubMed ID: 25016327
[TBL] [Abstract][Full Text] [Related]
15. The impact of risk information on patients' willingness to pay for autologous blood donation.
Lee SJ; Liljas B; Neumann PJ; Weinstein MC; Johannesson M
Med Care; 1998 Aug; 36(8):1162-73. PubMed ID: 9708589
[TBL] [Abstract][Full Text] [Related]
16. Willingness to pay and the sensitivity of willingness to pay for interdisciplinary musculoskeletal clinics: a contingent valuation study in Quebec, Canada.
Poder TG; He J
Int J Health Econ Manag; 2016 Dec; 16(4):337-361. PubMed ID: 27878690
[TBL] [Abstract][Full Text] [Related]
17. The contingent ranking method--a feasible and valid method when eliciting preferences for health care?
Slothuus U; Larsen ML; Junker P
Soc Sci Med; 2002 May; 54(10):1601-9. PubMed ID: 12061490
[TBL] [Abstract][Full Text] [Related]
18. If the price is right: vagueness and values clarification in contingent valuation.
Shiell A; Gold L
Health Econ; 2003 Nov; 12(11):909-19. PubMed ID: 14601154
[TBL] [Abstract][Full Text] [Related]
19. Empirical implications of response acquiescence in discrete-choice contingent valuation.
Yeung RY; Smith RD; Ho LM; Johnston JM; Leung GM
Health Econ; 2006 Oct; 15(10):1077-89. PubMed ID: 16518835
[TBL] [Abstract][Full Text] [Related]
20. The role of 'reference goods' in contingent valuation: should we help respondents to 'construct' their willingness to pay?
Smith RD
Health Econ; 2007 Dec; 16(12):1319-32. PubMed ID: 17328037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
